The Epidermal Growth Factor Receptor mutant (EGFRmut) is an important molecular subtype of non-small cell lung cancer (NSCLC) and is highly sensitive to anti-EGFR tyrosine kinase inhibitors (TKIs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.